JGCM
BSX icon

Joseph Group Capital Management’s Boston Scientific BSX Stock Holding History

Joseph Group Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4K Buy
432
+211
+95% +$11.5K ﹤0.01% 253
2026
Q1 		$13.9K Buy
221
+79
+56% +$6.32K ﹤0.01% 229
2025
Q4 		$13.5K Buy
+142
New +$13.9K ﹤0.01% 154

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Joseph Group Capital Management's BSX Position: Q2 2026 in Review

Joseph Group Capital Management increased its Boston Scientific (BSX) stake by 95% in Q2 2026, buying an estimated $11.5K and bringing the position to 432 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #253.

Joseph Group Capital Management first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Joseph Group Capital Management held 432 shares of Boston Scientific worth $18.4K as of Q2 2026.
  • Joseph Group Capital Management bought 211 Boston Scientific shares in Q2 2026, an estimated $11.5K.
  • Boston Scientific made up ﹤0.01% of Joseph Group Capital Management's portfolio in Q2 2026, its #253 holding.
  • Joseph Group Capital Management first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Joseph Group Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.